Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial

Andres M. Poveda; Frederic Selle; Felix Hilpert; Alexander Reuss; Antonella Savarese; Ignace Vergote; Petronella Witteveen; Aristotelis Bamias; Nana Scotto; Lada Mitchell; Eric Pujade-Lauraine

doi:10.1200/JCO.2015.63.1408

Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial

Andres M. Poveda
, Frederic Selle
, Felix Hilpert
, Alexander Reuss
, Antonella Savarese
, Ignace Vergote
, Petronella Witteveen
, Aristotelis Bamias
, Nana Scotto
, Lada Mitchell
, Eric Pujade-Lauraine

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

125 Downloads (Pure)

Original language	English
Pages (from-to)	3836-3838
Journal	Journal of Clinical Oncology
Volume	33
Issue number	32
DOIs	https://doi.org/10.1200/JCO.2015.63.1408
Publication status	Published - 10 Nov 2015

Access to Document

10.1200/JCO.2015.63.1408

1408Final published version, 84.8 KB

Cite this

Poveda, A. M., Selle, F., Hilpert, F., Reuss, A., Savarese, A., Vergote, I., Witteveen, P., Bamias, A., Scotto, N., Mitchell, L., & Pujade-Lauraine, E. (2015). Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial. Journal of Clinical Oncology, 33(32), 3836-3838. https://doi.org/10.1200/JCO.2015.63.1408

@article{7b93ea5edfb349ddb2492bc44a18139e,

title = "Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial",

author = "Poveda, \{Andres M.\} and Frederic Selle and Felix Hilpert and Alexander Reuss and Antonella Savarese and Ignace Vergote and Petronella Witteveen and Aristotelis Bamias and Nana Scotto and Lada Mitchell and Eric Pujade-Lauraine",

year = "2015",

month = nov,

day = "10",

doi = "10.1200/JCO.2015.63.1408",

language = "English",

volume = "33",

pages = "3836--3838",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "32",

}

Poveda, AM, Selle, F, Hilpert, F, Reuss, A, Savarese, A, Vergote, I, Witteveen, P, Bamias, A, Scotto, N, Mitchell, L & Pujade-Lauraine, E 2015, 'Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial', Journal of Clinical Oncology, vol. 33, no. 32, pp. 3836-3838. https://doi.org/10.1200/JCO.2015.63.1408

Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial. / Poveda, Andres M.; Selle, Frederic; Hilpert, Felix et al.
In: Journal of Clinical Oncology, Vol. 33, No. 32, 10.11.2015, p. 3836-3838.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial

AU - Poveda, Andres M.

AU - Selle, Frederic

AU - Hilpert, Felix

AU - Reuss, Alexander

AU - Savarese, Antonella

AU - Vergote, Ignace

AU - Witteveen, Petronella

AU - Bamias, Aristotelis

AU - Scotto, Nana

AU - Mitchell, Lada

AU - Pujade-Lauraine, Eric

PY - 2015/11/10

Y1 - 2015/11/10

U2 - 10.1200/JCO.2015.63.1408

DO - 10.1200/JCO.2015.63.1408

M3 - Comment/Letter to the editor

C2 - 26282651

SN - 0732-183X

VL - 33

SP - 3836

EP - 3838

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 32

ER -

Poveda AM, Selle F, Hilpert F, Reuss A, Savarese A, Vergote I et al. Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial. Journal of Clinical Oncology. 2015 Nov 10;33(32):3836-3838. doi: 10.1200/JCO.2015.63.1408